Implementation of AZD7442 (Tixagevimab/Cilgavimab) COVID-19 Pre-exposure Prophylaxis (PrEP) in the Largest Health Maintenance Organization in Israel: Real-world Uptake and Sociodemographic and Clinical Characteristics Across Immunocompromised Patient Groups
Hayek, Samah, Levy, Joseph, Shaham, Galit, Dagan, Noa, Serby, Danielle, Duskin-Bitan, Hadar, Yarden, Adva, Ferreira, Cátia, Livnat, Idit, Dube, Sabada, Taylor, Sylvia, Venkatesan, Sudhir, Balicer, Ran D., Netzer, Doron, Peretz, Alon
Published in Infectious diseases and therapy (01.06.2024)
Published in Infectious diseases and therapy (01.06.2024)
Get full text
Journal Article
Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge
Arbel, Ronen, Wolff Sagy, Yael, Hoshen, Moshe, Battat, Erez, Lavie, Gil, Sergienko, Ruslan, Friger, Michael, Waxman, Jacob G., Dagan, Noa, Balicer, Ran, Ben-Shlomo, Yatir, Peretz, Alon, Yaron, Shlomit, Serby, Danielle, Hammerman, Ariel, Netzer, Doron
Published in New England Journal of Medicine (01.09.2022)
Published in New England Journal of Medicine (01.09.2022)
Get full text
Journal Article
Web Resource
Effectiveness and safety of molnupiravir in the intended-use population: an observational cohort study
Abu Ahmad, Wiessam, Arbel, Ronen, Wolff Sagy, Yael, Battat, Erez, Sergienko, Ruslan, Friger, Michael, Yaron, Shlomit, Serby, Danielle, Zucker, Roy, Hammerman, Ariel, Duskin Bitan, Hadar, Peretz, Alon, Lavie, Gil, Netzer, Doron
Published in Clinical microbiology and infection (01.10.2024)
Published in Clinical microbiology and infection (01.10.2024)
Get full text
Journal Article
Implementation of AZD7442 in the Largest Health Maintenance Organization in Israel: Real-world Uptake and Sociodemographic and Clinical Characteristics Across Immunocompromised Patient Groups
Hayek, Samah, Levy, Joseph, Shaham, Galit, Dagan, Noa, Serby, Danielle, Duskin-Bitan, Hadar, Yarden, Adva
Published in Infectious diseases and therapy (01.06.2024)
Published in Infectious diseases and therapy (01.06.2024)
Get full text
Journal Article